TINA-QUANT HEMOGLOBIN A1CDX GEN. 3
Received Dec 10, 2024 · Event occurred Nov 18, 2024
Report 1823260-2024-03607 · MDR key 20895416
Device
Generic name
Glycosylated Hemoglobin Assay
Manufacturer
Roche DiagnosticsCatalog number
08445699190
Lot number
793043
Product problems
- Incorrect, Inadequate or Imprecise Result or Readings
- Incorrect, Inadequate or Imprecise Result or Readings
Patient
NA · Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
BASED ON THE PROVIDED DATA AND OBSERVED FAILURE MODE, THERE IS NO EVIDENCE OF AN INSTRUMENT AND REAGENT ISSUE. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT WAS CONSISTENT WITH DIFFERENCES IN TRACEABILITY AND STANDARDIZATION OF THE METHODS.
Additional Manufacturer Narrative
THE HBA1C REAGENT EXPIRATION DATE WAS NOT PROVIDED. THE COBAS PURE C303 ANALYTICAL UNIT SERIAL NUMBER WAS (B)(6). THE CUSTOMER MENTIONED THAT THEY HAD QC ISSUES. THE CALIBRATION VALUE WAS HIGHER THAN THE PREVIOUS CALIBRATION VALUE. THE FIELD APPLICATION SPECIALIST REQUESTED A REAGENT REPLACEMENT, AND RECALIBRATION AND QC RETESTING AND THE RESULTS WERE SUCCESSFUL. THE INVESTIGATION IS ONGOING.
Description of Event or Problem
WE RECEIVED AN ALLEGATION OF QUESTIONABLE RESULTS FOR 1 PATIENT SAMPLE TESTED WITH THE HBA1C ON A COBAS PURE C303 ANALYTICAL UNIT WHEN COMPARED TO A DIFFERENT SYSTEM. INITIAL RESULT: 6.53 %. THE CUSTOMER QUESTIONED THE INITIAL RESULT AND REPEATED THE SAMPLE. REPEAT RESULT: 5.9 % (TESTED ON ANOTHER SYSTEM). NO QUESTIONABLE RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE REPEAT RESULT WAS DEEMED TO BE CORRECT.